AMGN compared with CCCC: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CCCCC4 Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CCCCC4 Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34▲+3.70%· post 478.02· delayed

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

CCCCC4 Therapeutics, Inc.

3.11▼−3.24%· post 3.11· delayed

After hoursNov 4 '26delayed

Mkt cap$394.9MRevenue$7MQ2 FY26Revenue$36MFY25

Compare

After hoursNov 4 '26delayed

AMGNAmgen Inc

CCCCC4 Therapeutics, Inc.

478.34▲+3.70%post 478.02delayed

Price

3.11▼−3.24%post 3.11delayed

$249.4B

Mkt cap

$394.9M

Q3 FY26$10.4B

Revenue

$7MQ2 FY26

FY25$36.8B

Revenue

$36MFY25

AMGN478.34▲+3.70%vsCCCC3.11▼−3.24%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CCCC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only CCCC 6

MRKMerckcustomer

PFEPfizersupplier

BIIBBiogen MAcustomer

—Betta Pharmaunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

customer

2 more · CCCC chain ›

Price

rebased to 0%

AMGN, solidCCCC, dashed